Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mohabi Investment is a private investment group that focuses on strategic investments within the healthcare and biotechnology sectors. The firm is notably recognized as a major shareholder and lead investor in BiondVax Pharmaceuticals, an Israeli biopharmaceutical company specializing in the development of innovative therapeutic products such as Nanospabs (nanobodies). Mohabi Investment operates through various entities, including Mohabi Investment USA LLC, to manage its portfolio of life science assets. The group provides capital and strategic guidance to support the clinical development and commercialization of novel medical technologies. Its investment strategy emphasizes high-impact biotech platforms with the potential to address significant unmet medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MOHABI Investment USA.